Strides Pharma Science Limited (NSE: STAR)

Strides Pharma Science Revenue

Strides Pharma Science had revenue of 12.01B INR in the quarter ending September 30, 2024, with 20.18% growth. This brings the company's revenue in the last twelve months to 44.10B, up 16.66% year-over-year. In the fiscal year ending March 31, 2024, Strides Pharma Science had annual revenue of 40.51B with 9.83% growth.

• Revenue (ttm): 44.10B
• Revenue Growth: +16.66%
• P/S Ratio: 3.18
• Revenue / Employee: 14.39M
• Employees: 3,065
• Market Cap: 140.60B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	40.51B	3.63B	9.83%
Mar 31, 2023	36.88B	6.18B	20.13%
Mar 31, 2022	30.70B	-2.46B	-7.41%
Mar 31, 2021	33.16B	5.64B	20.49%
Mar 31, 2020	27.52B	5.74B	26.33%